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ABSTRACT
EFFECTS OF WEIGHT LOSS ON GUT MICROBIOTA
SAMITINJAYA DHAKAL
2019
Incidence of obesity continues to rise for several decades now. Despite the availability of
the multiple weight loss programs, losing or maintaining weight remains a universal
challenge. A comprehensive lifestyle modification is usually the cornerstone for
achieving weight loss. A wealth of new information on gut microbial responses to diet to
impact human health has introduced a new frontier in nutrition science that may help
better understand inter-individual response variations to weight-loss interventions. This
observational study examined the microbiota changes after weight-loss in relation to age,
sex, and body-composition features in adults. A 10% reduction in body weight resulted in
lower blood pressures as well as reduced total, android, and gynoid fats, indicating
potential improvement in body composition. Reduction in hemoglobin-A1C, a biomarker
for glucose metabolism, was only significant among those who had a higher weight-loss
response to the intervention. A general association between decrease in fat mass and
decrease in A1C was observed (r= 0.49, p=0.003). This association was further
augmented in individuals with higher-BMI (r=0.61, p= 0.002) and higher android fats
(r=0.55, p= 0.008), but absent in the corresponding low-groups. Males showed a higher
overall response to weight loss than females. Microbial richness increased after weightloss (p=0.017) and beta-diversity changes associated with age, BMI, waist:hip ratio, heart
rate, body fat%, and android region fat (all, p<0.05). Multiple novel correlations with
bacterial taxa were observed when the cohort was divided based on age, BMI, and the
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ratio between android and gynoid fats (all, p<0.05). Next generation MiSeq platform was
used for microbiome sequencing followed by data analysis using DESeq2 library in R.
An inverse correlation of Christensenella genus with Body Fat% and Parabacteroides
distasonis with A1C change corroborate with the previously known beneficial role of
these two microbiotas in independent cohorts. Functional inference from the
metagenomic shifts showed potential changes in bacterial metabolic capacity after
weight-loss. Findings may inform future studies investigating precise customization
potential of effective weight-loss strategies.
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1 INTRODUCTION AND LITERATURE REVIEW
It is estimated that currently approximately 600 million people around the globe are
obese. In addition, 1.9 billion people are overweight. Obesity is the condition in which
excessive fat accumulation occurs. It is abnormal or excessive fat accumulation may
impair health which reduces the quality of life of the people. Obesity develops over time
with consistently higher calories being consumed than burned for daily activities. The
balance between calories in and out and rate of weight gain differs for each person and
may be influenced by various factors such as: genetic makeup, hormonal imbalance,
dietary and physical activity patterns and practices[1, 2]. Obesity is a metabolic disorder,
which may increase the risk of various non-communicable conditions such as, diabetes,
heart disease and cancer. Because of this link with chronic conditions that are leading
causes of deaths, obesity is a growing public health crisis that is global in scope [3-7].
World Health Organization defines, overweight and obesity as abnormal or excessive fat
accumulation that may impair health. Obesity with its increasing prevalence is now
considered a global epidemic. Thus, to tackle this global epidemic, many dietary
approaches and eating patterns are available that focus on weight loss. All of the dietary
approaches focus and rely on a basic principle of energy balance. However, many
research have shown that everybody doesn’t respond to the weight loss diet in the same
way. There are multiple factors such as body weight, composition, activity levels, genetic
factors, epigenetic factors responsible for the difference. One possibility that could be an
important response determining factor for the variation of the weight loss individually is
Gut microbiota.
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1.1 Gut Microbiota
Diversity in the microbiota found in human body:
Humans have evolved to live with microbes for million years. The human gut contains
large number of microbiotas, it is said that, the number is as large as 1013. The majority
reside in our colon where densities approach 1011–1012cells/ml, the highest recorded for
any microbial habitat[8]. Intestine is the largest residence of microorganism community
in our body. Trillions of these microbes exist mainly inside our intestines and on skin.
Most of the microbes in our intestines are found in a pocket of our large intestine called
cecum and they are referred to as the “gut microbiome”[9]. We are in the midst of a
revolution in our understanding of human microbiome. If we go back a decade, our
knowledge regarding inventory of microbiome that inhabit different parts of the human
body was little, we didn’t have much idea about the varying levels of complexity, and
their relation to microbiomes in other species. Latest improvements in the technologies
for collecting and analyzing DNA sequence data make these questions accessible[10].
Many types of microbiota reside inside our body, among them bacteria are the most
studied. They function as an extra organ in our body and play a huge role in our
health[11]. Human beings are first exposed to microbes when they pass through mother’s
canal. However, new evidence suggests that babies may come in contact with some
microbes while inside the womb[12].

Commensal bacteria co-evolved with their hosts and hence are not pathogenic under
normal conditions. Surprising number of correlations has been found between the aspects
of the microbiome and number of human diseases. The dominant residents of human gut

3

are Gram negative strict anaerobes, including Bacteriodes, Bifidobacterium,
Fusobacterium, Eubacterium and Peptostreptococcus[13]. However, under specific
conditions, this ecological homeostasis cannot be maintained, leading to pathologic
imbalance of gut microbiota, termed dysbiosis. Dysbiosis triggers a multitude of chronic
human diseases, such as inflammatory bowel diseases, intestinal cancer, obesity, type 2
diabetes, atherosclerosis, and alteration of bone metabolism[10]. Gut microbiota not only
directly associates with the food that we eat but also involve triggering immune cells
underlying a single layer of gut epithelium. There exists a mutually beneficial association
between the resident gut microbiota and a healthy host. Microbiome-centric intervention
has also been used recently and is found to be very effective in treatment of specific
disorders like recurrent Clostridium difficile infection [14].

Difference between Microbiota, Metagenome and Microbiome:
These are the few terminologies that are used extensively and frequently interchangeably
but do not mean the same. They are properly defined below:

Microbiota
The term microbiota was first defined by Lederberg and McCray[15], who emphasized
the importance of microorganisms inhabiting the human body in health and disease. This
microbial census is established using molecular methods relying predominantly on the
analysis of 16S rRNA genes, 18S rRNA genes, or other marker genes and genomic
regions, amplified and sequenced from given biological samples. Taxonomic assignments
are performed using a variety of tools that assign each sequence to a microbial taxon
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(bacteria, archaea, or lower eukaryotes) at different taxonomic levels from phylum to
species[16].

Metagenome
The collection of genomes and genes from the members of a microbiota. This collection
is obtained through shotgun sequencing of DNA extracted from a sample (metagenomics)
followed by assembly or mapping to a reference database followed by annotation.
Metataxonomic analysis, because it relies on the amplification and sequencing of
taxonomic marker genes, is not metagenomics. Metagenomics is the process used to
characterize the metagenome, from which information on the potential function of the
microbiota can be gained[16].

Microbiome
This term refers to the entire habitat, including the microorganisms (bacteria, archaea,
lower and higher eurkaryotes, and viruses), their genomes (i.e., genes), and the
surrounding environmental conditions. This definition is based on that of “biome,” the
biotic and abiotic factors of given environments. Others in the field limit the definition of
microbiome to the collection of genes and genomes of members of a microbiota. It is
argued that this is the definition of metagenome, which combined with the environment
constitutes the microbiome. The microbiome is characterized by the application of one or
combinations of metagenomics, metabonomics, metatranscriptomics, and
metaproteomics combined with clinical or environmental metadata[16].
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Gut microbiota within and between individuals:
When the above factors are taken into consideration, together with host genotype and
environmental factors that influence the composition of the microbiota, it can be
understood that it is challenging to define and compare microbial community structures
within and between specified intestinal niches of an individual at the different point of
their life, let alone to compare the microbiota among individuals living in different
geographical location or in a distributed population[9, 17].

However, there are some general features that are nearly common among the individuals.
In adults, >99.9% of the cultivable bacterial population are obligate anaerobes.
Collectively, the microbiome gene is 100 times more than our own human genome[9].
The main member is anaerobic bacteria, it includes, 500-1000 different species. The
human intestinal microbiota is mainly composed of bacterial phyla Bacteroides,
Clostridium, Lactobacillus, Fusobacterium, Bifidobacterium, Eubacterium, Peptococcus,
Peptostreptococcus, Escherichia and Veillonella [18, 19]. It is also consistent between
the individuals that the population density of the microbiota increases by the magnitude
of about 8 orders from the proximal small intestine to colon. In the same way,
biodiversity also consistently increases[9].

A research to identify the difference between diseases associated microbiota community
and normal community is particularly difficult because the microbial community varies
significantly in unrelated individuals as measured by sequencing 16S rRNA genes[20,
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21]. A previous research has shown a significant difference in Western and Non-Western
population. These researches show a distinct difference between industrial nation such as
USA and remote countries. Western microbiomes generally bear a greater amount of
Bacteroides while non-western microbiomes generally contain greater amount of
Firmicutes and Proteobacteria [22, 23]. Although the exceptions to this trend exists, if
we look at the broader picture, these studies point to the fact that there is no single
“human microbiome”. Also, our commensal microbiomes assume a wide range of
configurations[22-24].
It is found out that the microbiota is somewhat similar among family members. In
addition, with the influence of both genetics and environmental influence, twins have
more similar microbiota compared to that of random individuals[21, 25, 26]. Although
the microbiota is found out to be similar between family members, it is well known that
the microbiota is highly influenced by the early environment exposure and is also shaped
by the mode of delivery. Other factors that can contribute to the difference in gut
microbiome of infant are the time of gestation and breast feeding[26, 27]. Thus, the
human microbiota can be considered dynamic and changes throughout the lifetime
according to environment, activity, food, and drug exposure.

Nutrient metabolism function of gut microbiota:
Nutrient and drug Metabolism:
The present microbiota acts as a metabolic organ in our body. Many dietary components
are resistant to initial digestion in small intestine. Those components are fermented by the
microbiota of large intestine, producing short chain fatty acids. Those SCFAs are
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absorbed across the colonic mucosa. It is estimated that up to 10% of total dietary energy
comes from SCFA in human being[28].

Gut microbiota has also shown the action of suppressing the inhibition of lipoprotein
lipase activity in adipocytes, which is a positive impact on fat metabolism[29]. In
addition, gut microbiota is also enriched with an efficient protein metabolizing capacity.
It functions via the microbial proteinases and peptidases in collaboration with human
proteinases. There are many amino acid transporters on the bacterial cell wall. Those
transporters facilitate amino acids into small signaling molecules and anti-microbial
peptides. Some e.g. are, conversion of L-histidine to histamine by the bacterial enzyme
histamine decarboxylase which is coded by bacterial hdcA genes[30], conversion of
glutamate to gama amino butyric acid by glutamate decarboxylase which is coded by the
bacterial gadB genes[18]. Another major metabolic function of gut microbiota is
synthesis of Vitamin K. several components of Vitamin B and in the several pathways of
drug metabolism, also known as xenobiotic metabolism[31].

Factors affecting normal gut microbiota in an individual:
Mode of Delivery at birth:
It is widely accepted that the fetuses are sterile in uterus. The microbial colonization of
the newborn starts during and after birth. Thus, mode of delivery is the first factor that
affects infant’s microbiota. Previous research suggests that vaginal delivered infants are
colonized by maternal vaginal and fecal bacteria including Lactobacillus, an oxygen-
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tolerant group of microbes and Bifidobacterium species [27]. However, infants born via
C-section are not directly exposed to the maternal vaginal and fecal microbiota. It is
found out that the infants born via C-section are colonized by the microbes associated
with skin and hospital environment[32]. The microbiota of the babies born from Csection have more of a type of bacteria Proteobacteria and less of Bifidobacteria. Csection also delays the colonization of Bacteroidetes in infant. Thus, the bacterial
diversity in infant delivered via C-section is less compared to the infant delivered via
vaginal route[33].

Age:
Modern medicine played a vital role to increase the lifespan of human being. With the
increase, most citizens of developed countries are now looking forward to four-scoreyears plus on the planet. The main challenge now is to reduce the severity of the
morbidity that precedes death. Chronological aging accumulates disorders, which causes
frailty. An “organ” in the human body that does not age according to the general
trajectory of physiological decline is the microorganisms in the gut. Bacterial cells do not
age, but people growing older begin to experience comorbidities associated with the gut
and with gut bacteria. The main question is how the microbiota in the human gut might
affect the aging process, or if it affects the process at all?
It has been shown that the composition of the elderly differs considerably between
individuals in the ELDERMET study[34]. The researchers observed a shift in the
microbiota towards a Bacteroidetes-predominated population in frailer older individuals
compared to younger individuals. Nevertheless, the variation in the microbiota profiles of
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the elderly subjects was large, so the trend is minimally informative in terms of
prediction of the phenotype. The large variation is typically explained by external factors
influencing the microbiota, such as diet, exercise and medication[35].

Initially, after the inoculation, gut microbiota in infant appears unstable and devoid of
diversity. By the age of 3, it stabilizes, diversifies and acquires about half the similarity of
adult gut microbiota. Microbiota changes drastically between infant and adult stages[36].
The shift occurs in the dominance of Bifidobacterium to genera within Bacteroidetes and
Clostridia. This change reflects from primarily lactate metabolism and plant
polysaccharide breakdown to short-chain fatty acid production and vitamin (Cobalamin)
and carbohydrate metabolism[25]. Although, a very few researches are done on this
topic, the composition of gut microbiota is thought to change during the aging process. In
a research done on Japanese elder population, the association between the advanced age
with the composition and stability of the gut microbiome was observed[37]. Another
research done by Biagi et al showed low diversity in older people compared to younger
adults. The research also showed the specific change in Firmicutes subgroup and
enrichment of Proteobacteria[38].

One other research assessed major bacterial groups in gut such as, Clostridium leptum,
Clostridium coccoides, Bacteroidetes, Bifidobacterium, Lactobacillus and Escherichia
coli. They found a significant difference of the microbiota between the age group. They
found high level of E. Coli and Bacteroidetes in elder population compared to younger
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adults. They also observed significant difference in the ratio of Firmicutes to
Bacteroidetes between infant, young adults and elderly population[39]. While, a few
researches have shown that the adult microbiota remains roughly stable from 30s to 70s
and suggests the changes that occur in the microbiota of aging individuals are unclear.
Hence, with the evidence of present research, precise etiology of age-related gut
microbiota change remains incomplete[38-40]. There is evidence that loss of gut
microbiota diversity can occur and does affect the aging process. The loss of diversity in
the core microbiota groups is associated with increased frailty and reduced cognitive
performance, however, the significant association with chronological aging is not found.
Thus, with the evidence of above researches, we can say that the gut microbiota changes
with the age and keeps on changing throughout our life.

Diet:
Studies show that there is a difference in gut microbiota richness and diversity between
the infants consuming breast milk and formula milk. It is well-known that besides
meeting the nutritional requirement of the infants, breast milk also contain several
bioactive compounds that are not available in formula milk. One nutrient that infant
cannot metabolize but is beneficial to microbiota is human milk oligosaccharides (HMO).
This compound is not available in the formula milk as it cannot be replicated in the lab
till date[41].
Even in adulthood, diet continues to be a very important factor in shaping the richness,
diversity and composition of gut microbiota. In general, previous research suggests that
the diet rich in fruits, vegetables and fibers is associated with a higher richness and
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diversity of the gut microbiota[42]. In one previous research, substantial alteration of
species composition of the colonic microbiota was seen with the diet rich in nondigestible carbohydrate. In the research, the increase in the richness of Christensenella
minuta was seen. This was previously reported to be a heritable microbiota[43]. One
other study showed the change in the gut microbiota diversity with increased
consumption of resistant starch diet. The research showed to increase in the abundance of
insoluble carbohydrate metabolizing organisms of the Firmicutes phylum such as
Ruminococcus bromii, Roseburia and Eubacterium rectale[42]. Another study suggested
that there is a decrease in the abundance of Firmicutes phylum with the western type
(high meat and high fat) diet. The research also showed an increase in the bile tolerant
organisms such as Alistipes sps and Bacteroides sps[44]. Similar result was seen in
another research done by the collection of fecal microbiota from European children and
children from rural village of Burkina Faso. They observed the fecal microbiota
dominated by Bacteroides enterotype in European children, who were consuming typical
western diet i.e. high in animal protein and fat. Whereas, the fecal microbiota of the
children in rural village of Burkina Faso, who were consuming diet i.e. low in animal
protein and high in carbohydrate was dominated by Prevotella species[45]. Hence, with
those evidence we can say that diet has a major effect on gut microbiota composition.

Other factors
The other factors like physical activity or level of regular activity also has a major role in
the shift of gut microbiota in both quantitative and qualitative way[46]. In addition, there
are other factors such as, overall outside environment and degree of sanitation that can
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alter the gut microbiota of an individual significantly. External factors such as,
Antibiotics, Prebiotics, surgical interventions, bacterial infection and other diseases
(diabetes) can significantly change the number and ratio of normal gut microbiota.
Though, most of the changes are reversible, some temporary alteration in microbiota
might have significant effect on human health[29]

1.2 Obesity in general:
Obesity is a preventable metabolic disorder that has nearly tripled from 1975 to 2016. In
a recent WHO global estimate of 2016, 39% adults, aged 18 years and over were
overweight or obese. The percentage was almost equal in both the sexes, 39% of men and
40% of women overall were overweight or obese. Also, WHO estimated that about 13%
of world’s adult population were obese, 11% of men and 15% of women[6]. In case of
children, the prevalence of overweight and obesity dramatically increased from 4% in
1975 to over 18% in 2016. The numbers were similar in case of boys and girls in the age
group[6]. I did not get time to double check your references—make sure they are cited
correctly and appropriately.
Obese people are at increased risk for many serious diseases and health conditions
compared to a normal or healthy weight people.
The consequences related to obesity are listed below[47]:
•

Cardiovascular diseases like heart disease and stroke. They are the leading cause
of death.
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•

Diabetes.

•

Sleep apnea and breathing problems

•

Mental illness such as clinical depression, anxiety and other metal disorders.

•

Muscoskeletal disorders such as osteoarthritis.

•

Gall bladder diseases.

•

Many forms of cancers such as, endometrial, breast, ovarian, prostate, liver,
gallbladder, kidney and colon.

•

Body pain and difficulty in functioning

•

Decreased quality of life.

Relationship of Gut microbiota and Obesity:
The basic theory of relation between the obesity and gut microbiome is that, the gut
microbiome of the obese subjects has a higher capacity to harvest the energy from the
indigestible components of the food[48]. In addition to that, the microbiota also regulates
the expression within themselves that promotes the deposition of the absorbed energy in
adipocytes. The microbial suppression of intestinal fasting induced adipocyte factor
promotes the adiposity by increasing lipoprotein lipase activity which then promotes
triglyceride storage in adipocytes[49].

Combination of above mechanism suggests that there is a close relation between the
composition of gut microbiota and host energy balance and homeostasis. There are
enough evidences to suggest that gut dysbiosis contributes to the development of obesity
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and other complications. A research was done on “conventionally raised” mice and
“germ-free” mice. The research found out that serum metabolome of “conventionally
raised” mice was characterized by increased levels of energy metabolites such as, pyruvic
acid, citric acid, fumaric acid and malic acid, while levels of cholesterol and fatty acids
were reduced in conventionally raised mice. They also found out the microbiota in
conventionally raised mice modified a number of lipid species in the serum, adipose
tissue and liver. Its largest effect was on triglyceride and phosphatidylcholine species. In
addition, triglyceride levels were lower in serum but was higher in adipose tissue and
liver of conventionally raised mice. This result is consistent with the increased lipid
clearance[50]. The research is an evidence that the gut microbiota affects both host
energy and lipid metabolism and shows the role in the development of metabolic
diseases.

In another study, germ free mice were inoculated with microbiota from obese and lean
mice. The significant difference between two groups was observed. The germ-free mice
receiving microbiota from obese mice became significantly fatter than recipient germ free
mice that were inoculated with microbiota from lean mice[48, 51]. In a human study done
by Jumpertz et al, they observed negative relation of fecal energy loss with the proportion
of Firmicutes and positive relation of fecal energy loss with the proportion of
Bacteroidetes. They reported, 20% increase in Firmicutes and 20% decrease in
Bacteroidetes to be associated with 150kcal increase in the energy harvest. Furthermore,
they also found out that overnutrition to be associated with proportionally increase in
Firmicutes and decrease in Bacteroidetes[52].
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Thus, with the evidence provided by various research, we can say that the gut
microbiome affect obesity significantly. Furthermore, gut microbiome influences the
calories that body absorbs, it affects the obesity associated inflammation and it also
affects insulin resistance.

Thus, with all the above evidences, we can say that gut microbiota has a significant role
in obesity and this relation also changes the way people respond to weight loss
intervention. With the various research showing the change in the microbiota
composition during the stages of life, we can assume that age might have a potential role
in the response to the weight loss intervention. In our research, we try to utilize the
dietary intervention done by a commercially available weight loss program to find out if
age related changes in the gut microbiota contributed to an individual’s response to
weight loss intervention.

1.3 Weight Loss
The cornerstone of therapeutic intervention for the treatment of obesity is weight loss via
lifestyle modification[53]. The modification may include, hypocaloric diet and/or
increased physical activity. In addition, there are other invasive methods available like
bariatric surgery, which includes gastric bypass, sleeve gastrectomy, adjustable gastric
band, and biliopancreatic diversion with duodenal switch[54]. The most common, noninvasive and safest way of weight loss is lifestyle modification. Generally, the weight
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loss resulting from lifestyle change is between 5-10% of the baseline weight[55]. This
change might not be significant to some but typically, modest amount of body weight
change can result in therapeutically beneficial effect in some metabolic diseases [10].
Thus, lifestyle interventions for weight loss are the most important and safest way of
obesity therapy. However, the long-term weight maintenance is still a very difficult task.
It is a well-known fact that, although it is possible to achieve an effective weight loss by
lifestyle modification in a few months, most of the people regain their weight back within
1 year[56]. There are a couple of factors associated with the weight regain. The primary
reason for the weight regains is the people going back to original unhealthy lifestyle and
not keeping the healthy diet habit they maintained during the weight loss period. The
other important and often overlooked factor is that during the weight loss period, most of
the people lose their fat mass as well as their muscle mass[57]. So, due to the loss of that
muscle mass, the metabolism is often compromised as the muscle mass is positively
associated with resting metabolic rate[58]. Since the maintenance of the weight loss is
often the hardest part, a successful weight loss strategy needs to have a proper focus on
the weight maintenance phase. Focusing on the controlling the lean mass loss during the
weight loss intervention can be an effective method.

Losing weight and maintaining is hard and is supported by the literature as most people
struggle with it [59]. However, weight loss is very important for the prevention and in
many cases for the treatment of the metabolic diseases. Various researches have shown
improvements in biomarkers relating to diabetes, cardiovascular disease and cancer risk.
In addition, the researches done in smaller scale has shown that the induced weight loss
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to be correlated to improvement in hypertension and metabolic syndrome [11, 12].
National Institutes of Health Obesity Education Initiative Expert Panel suggested a
caloric deficit of 500-1000kcal/day using an individualized dietary strategy combined
with 45 minutes of moderate-intensity physical activity 5 days/week[60]. Similarly, US
department of Agriculture suggests individuals to engage close to 1 hour of moderate to
vigorous intensity exercise on most days of the week without exceeding caloric intake
requirements. In another guideline by Institute of Medicine, 1 hour per day of moderate
to intense physical activity is recommended which is coupled with a caloric deficit.

Diet and weight loss:
There are numerous approaches and strategies to weight loss, but the optimum way is still
debated. Different diets give importance to different macronutrient ratio but from the
research available till date, we cannot claim one approach to be better than the other.
Number of diets are available in the market claiming to be the best. Some of the famous
ones are, DASH (Dietary approach to stop hypertension), Mediterranean diet, Flexitarian
diet, Weight watchers diet, MIND (Mediterranean in Dash) diet, TLC ( Therapeutic
lifestyle changes) diet, Volumetrics diet, Mayo clinic diet, Ornish diet, Fertility diet,
Vegetarian diet, Jenny Craig diet, Asian diet, and Flat belly diet[61]. There are many
more diet but all of them rely on a fundamental conceptual basis of energy balance for
weight loss, i.e. [62]. It is not clearly understood about the dietary protocols that is most
efficient in consistent and sustainable weight loss[54, 63-65]. Small sample size, under
representation of men, limited generalizability, a lack of blinded ascertainment of
outcome, a lack of data on adherence to assigned diets and a large loss of follow up limit
the interpretation of many weight loss trials. [66]
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There are various types of diets used for weight loss. All the different diets have varying
number of macronutrients as well as micronutrients. Many research has shown the high
protein, low carbohydrate diet to be more effective than moderate carbohydrate diet. [67,
68] However, there are some conflicting results as well. Some research showed that a
vegetarian diet, i.e. very low on fat and high on carbohydrate to be superior for weight
loss. Other diets such as, paleo diet, Mediterranean diet, Atkins diets have all shown to be
effective in weight loss.

All the different diets are important in their own way, not all diet suits for everyone. So,
with all the various options, weight loss is looking more achievable. The clear answer of
superiority of diet is yet to be found out. In one research, done by Frank M Sacks et al,
they included 811 overweight individuals. The research worked on various type of diets
with varying concentration of macronutrients. No effect on weight loss was seen in the
varying amount of macro nutrients. Regardless of the macronutrient composition, most of
the participants lost significant amount of weight in the research. They concluded that the
reduced calorie diets to be associated with the clinically meaningful weight loss
regardless of the macronutrients they emphasize. Thus, the findings in this field hasn’t
been very consistent.[69]

Low Carbohydrate diet:
Low fat diet has been a popular method of weight loss since last few decades[1].
Recently, the interest has shifted from low fat to low carbohydrate diet. The low
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carbohydrate diet approach originates from the hypothesis of lowering insulin. Insulin is
an important hormone to produce an anabolic, fat-storing state. Lowering the insulin level
is believed to help in improving cardiometabolic function and in weight loss[70]. The
other important hypothesis favoring the low carbohydrate diet approach for weight loss
over other approach is that the fats and protein increase the satiety and produce less
concomitant hypoglycemia[2]. Number of different low carbohydrate diet options are
available such as, Atkins diet, Paleo diet, Ketogenic diet (very low carbohydrate diet),
low carb Mediterranean diet, etc.

Low Fat diet:
In the past, fat was often considered to be a bad thing and healthy diet were often
considered to be fat free. Due to that reason, the low-fat product skyrocketed in that
period. Fat intake then has always been targeted to decrease the incidence of the
metabolic diseases. However, decreasing the fat intake hasn’t really lowered the
metabolic disease incidence in the western world[71]. Usually the low fat diets are low
in calories because fat has the 9 kcal per gram compared to 4 kcal per gram in protein
and carbohydrate[72]. Thus, low fat diet makes it easier to be on a negative energy
balance, which is known to be the major driving factor for the weight loss. Low fat diet
hasn’t only been linked to the weight loss but has also been considered an effective
approach to mitigate metabolic syndrome[73]. Traditionally, Asian diet is higher in
carbohydrates and vegetables and are usually low on saturated fat. As a result, the
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prevalence of the metabolic syndrome is lower in Asian countries compared to western
countries[74]. However, things are changing with the recent advancements, the western
type diet is increasing in Asian countries as well. Consequently, the prevalence of the
metabolic syndrome is on the rise[75]. Correlation always doesn’t signify causation, but
this is an interesting field for the research. However, some conflicting finding has been
reported about the low-fat diet. A research done by Park et al (2015) has shown a higher
prevalence of metabolic syndrome in low fat consuming cohort[76]. There was a
significant association of metabolic syndrome components with the daily fat intake.

Ketogenic diet or very low-carbohydrate diet:
The ketogenic diet takes an entirely different approach to weight loss and health
improvements. Ketogenic diet changes the regular fuel system of the body. It changes the
fuel source which is glucose to ketone bodies to stay energized. Studies on the ketogenic
diet vary in their daily limit of carbohydrate intake; carbohydrate intake is roughly
maintained below 50 grams of net carbohydrate per day[2].

A primary concern related to restricted calorie diet is the amount of fat free mass that is
lost together with fat mass. Such action of low caloric diet may induce sarcopenic
obesity[77]. This type of obesity constitutes a double impact on the health of people
because the reduction of muscle mass and strength is related to the cause of
cardiometabolic disorders such as myocardial infarction, stroke and other health
outcomes[78]. For this reason, it is important to find the weight loss strategy that promote
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preferential loss of fat mass coupled with prevention of muscle mass and its functional
status. One approach, i.e. very low carbohydrate diet has gained recognition in the face of
modest supportive scientific evidence[79, 80]. When we are not getting enough sources
of carbohydrate externally from our diet, our body does a unique phenomenon. The thing
that happens in our system is that, due to inadequate carbohydrate consumption, the
regular metabolic process wouldn’t be possible. There would be a large build up in
Acetyl CoA in the body. In a normal metabolic process, the Acetyl CoA goes through
TCA cycle as a step to produce usable energy (ATP) whereas, in low carbohydrate diet,
the large buildup of Acetyl CoA causes it to change into ketone bodies. This stage is
known as ketosis. Furthermore, these ketone bodies would then be used as a source of
energy because of lack of glucose[81]. This is a natural process initiated by the body to
help us survive when food intake is low. However, blood glucose level is still maintained
by liver precisely from other sources such as amino acids and glycerol[82].

There have been a few previous studies that have suggested that very-low calorie
ketogenic diet could be effective tools to manage overweight and obesity[83, 84]. The
weight reducing action of ketogenic diet is rapid and long lasting. A study done by
Moreno et al found out the significant decrease in fat mass even after 2 years of ketogenic
diet. In the research, significant weight loss was observed throughout the study. They also
show the reduction of the weight to be mostly fat mass and visceral fat tissue. In the
research, there was a mild initial loss of fat free mass which was followed by subsequent
recovery[83]. This was explained as a result of change in body water. In addition,
adequate muscle strength was preserved during the course of the diet. The research
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showed that the ketogenic diet was superior to normal low-calorie diet in significant way.
The volunteers in the ketogenic diet lost more adiposity and maintained the effect 2 years
later as well. The research showed a significant drop in visceral fat, which suggests
ketogenic diet could be beneficial for rapid elimination of some metabolic syndrome
associated with visceral fat[83].

In another study done by Goday et al, significantly larger weight loss and reduction in
waist circumference was seen in ketogenic diet volunteers compared to low calorie
participants. They also demonstrated the decline in A1C and glycemic control in
ketogenic diet participants. They concluded the ketogenic diet to be more effective than
standard hypocaloric diet in reducing body weight and improvement of glycemic control
of the body[85].

Furthermore, in another research done by Yancy et al, a low-carbohydrate diet had a
better participant retention, and greater weight loss compared to a low-fat diet. Serum
triglyceride levels decreased more, and high-density lipoprotein cholesterol increased
during the active weight loss period in the low-carbohydrate diet than with the low-fat
diet[79, 80]. However, like in case of many other diets, there is no research showing
effectiveness and safety of a ketogenic diet over long-term for sustaining a healthy
weight.

Aging and weight loss:
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With aging, losing weight becomes more difficult. This happens due to various reasons
from increasing stress levels to a slowing metabolism to the inevitable loss of muscles[1].
It is well documented that as individuals age, the composition of the body changes,
whether or not there is presence of changes in body weight[86]. There have been several
studies on this topic and the results has shown that the fat mass increases and lean mass
decreases with age. However, it is not clear why such changes occur[87]. In general, as
individual age, the percentage of body fat increase whereas, the percent of lean mass and
bone mineral density decrease[87]. In addition, the increase in fat mass is distributed
more specifically in the abdominal region. This type of fat is associated with
cardiovascular disease and diabetes[88]. It is determined that the increase in percent fat
mass was mostly due to reduced lean mass, whereas the increase in abdominal percent fat
mass was due to the alteration of the fat distribution with aging. This increase of
abdominal visceral fat is more dramatic in women (4 times increase) than in men (2 times
increase)[89]. The reason for such shift in visceral fat distribution is not properly known
but the hormonal environment change with the aging is considered to be a driving factor.
Hormonal factors may be age related insulin resistance or decrease of gonadal hormone
with age[90]. This explains the age-related differences in body composition and the
increase in visceral fat even the whole-body percent fat mass remains stable[87].

In a study done by Krems et al, they compared the RMR of young (20-35 yrs), older (>60
years) men and women. The RMR was found out to be lower in older individuals
compared with younger individuals, even after adjusting for fat free mass, fat mass and
smoking history. They also calculated RMR based on estimated organ masses. For young
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men, measured and calculated RMR were not significantly different, whereas, for young
women and older men and women, measured RMR was lower than calculated RMR. The
differences between calculated and measured RMR were greater for the older group than
the younger group[91]. Similar results were obtained by Frisard et al when comparing
young (20-35 years), old (60-74 years) and very old (>80 years) individuals. RMR was
lower in older and very old individuals than in young individuals after adjusting for fat
free mass, fat mass and gender[92].

A longitudinal study on nutrition and health status of an aging German population was
done. The study looked into the energy expenditure during the course of aging in men
and women over 60 years of age. Over the 8 years follow up period, subjects lost height,
increased BMI and fat mass and decreased Fat free mass and waist to hip ratio with no
change in weight. After adjusting for body composition, men had 5% reduction in RMR
per decade and women a 3% reduction per decade. This research concluded that the
decline in RMR was not just due to changes in body composition[93]. From above
evidences, it is still not clear the exact mechanism that leads to increase in fat percent and
visceral fat due to aging. However, the evidences and existing data, indicate that the
weight loss can become challenging as people age.

Gut microbiota’s role on weight loss:
The exact relation between obesity and gut microbiota might not be very clear but that
the gut microbiota has a major development contribution to obesity and other metabolic
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disorders is clear from recent research. Ley et al [94] reported on relationship between
obese human subjects, gut microbiota, and weight loss. First, they reported the relative
proportion of Bacteroidetes to be decreased in obese people compared with lean people.
This result is consistent with Jumpertz et al [52]. They also observed significant increase
in Bacteroidetes in obese people going on a low-calorie weight loss diet over 12 months.
They reported the increase of Bacteroidetes from 2% of total fecal bacteria to >20% of
total fecal bacteria. In addition, total bacterial numbers did not differ between obese and
non-obese subjects when on weight maintenance diet[94].

In another research done on human subjects undergoing weight loss diet, with the help of
16s rDNA with quantitative real time PCR, obese individuals showed a significant
increase in total bacterial abundance after weight reduction. The research reported a
significant decrease of the ratio of Firmicutes/Bacteroidetes during intervention. This
finding is similar to the finding of Ley et al[94]. In addition, increase in Lactobacilli was
also observed in the research. Furthermore, a significant correlation was also observed
with the differences in weight loss percentage[95].

However, a research done by Duncan et al does not agree with the finding of above
research. In a research performed on human subjects in Scotland, they found no
significant difference in percentage of total fecal bacteria present as Bacteroides on
weight loss diet or weight maintenance diet. They did not observe any significant
relationship between changes in percentage of Bacteroides in the feces and the amount of
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weight lost. Although, they observed a marginally significant weak positive correlation
between the change in the percentage of Bacteroidetes and weight loss expressed as
percentage of initial body weight, this research does not support the relation of weight
loss and gut microbiota at phylum level[96]. One major difference in the research done
by Duncan et al [96] and above researches [94, 95, 97] is that, they used FISH
(Fluorescent in situ Hybridization) technique compared to 16S rRNA genes obtained by
PCR using Bio Rad MyiQ cycler and amplification condition, which could be a reason
for contrasting result.
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2 MATERIAL AND METHODS
Study design and Participants:
The study was conducted as a prospective cohort, 12-week, observational study.
All anthropometric data, DXA analysis and stool collection was done before the
participants went on the proprietary diet (see Test Diets for detail) and after the 12
weeks period. Participants were recruited from among the incoming first-time
members of the Profile by Sanford personalized weight loss program that
incorporates one-on-one health coaching and a low-calorie, easy-to-follow,
personalized diet plan. Although Profile has retail locations all over the United
States, participants for the current study were recruited from Brookings area
location in South Dakota on a first-come-first serve basis once they met the
inclusion criteria of the study. From the 58 subjects recruited, 39 completed at
least 12 weeks of Profile diet. The participants who dropped out of the Profile diet
before week-12 were excluded from the study. Out of 39 participants, 3 were
excluded from data analyses. Two participants were excluded because of
unavailability of adequate stool sample and one was excluded because of very low
microbiome count in the stool. The remaining 36 participants were grouped based
on the difference in Age, BMI, AG ratio, and Sex. Exclusion criteria included
pregnancy, lactation, probiotic, prebiotic and antibiotic use, cancer, diabetes,
immune compromised state, and other conditions that would affect the ability to
provide informed consent or comply with the protocol.
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Test Diets
Participants of the study were on a proprietary, nutritionally balanced diet plan.
The diet was based on the principle of portion control and caloric reduction
through lowering of carbohydrates and fats while increasing protein intake.
Dietary-intake data was collected by the research team using 24-hour dietary
recall survey at baseline (right before participants switched to Profile-diet) and
after 12 weeks into the “Reboot phase” of the program. Research team members
engaged during the survey process, actively asking questions to help with precise
recalling and data entry. For Profile-meals, nutrition data was obtained from
package labels. The 12-week time period was previously observed as an optimal
average time window when majority of Profile participants tend to achieve their
weight loss goals (information obtained through personal communication with Dr.
McCormack). During this initial weight-loss phase, participants consume
specially formulated food items purchased from Profile. Once the weight loss goal
is reached, the members are slowly guided to transition to natural food sources to
help sustain the weight loss (Adapt-phase of the program). Although an active
lifestyle is generally encouraged, the program does not require any specific daily
activity.

Anthropometric measurements
A1C, height, weight, waist circumference, and blood pressure were measured at
the beginning and at the end of each intervention period following standard
procedures that were previously described[98]. Briefly, height was measured
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using a stadiometer and recorded to the nearest 0.5 cm. Body weight (BW) was
measured on an electronic scale with the subjects in light clothes and no shoes and
was recorded to the nearest 0.1kg. Gulick tape was used to measure the waist (at
navel) and hip (at the widest part of the hips) circumferences to the nearest 0.5
cm. Blood pressure was measured using a digital sphygmomanometer in a sitting
position. A1C was measured using A1C Now®+ device (PTS Diagnostics,
Indianapolis, Indiana). In addition, body composition (total fat mass, b, android
fat, gynoid fat, and fat-free mass) was determined by total-body, dual energy, xray absorptiometry (DXA) scanning as described previously[99].

Community structure analysis of gut microbes
The stool samples were sent to Second Genome (South San Francisco, CA) for
16S sequencing and operational taxonomic unit identification. The nucleic acid
isolation was performed with the Qiagen MagAttract PowerMicrobiome
DNA/RNA Kit according to manufacturer’s guidelines and optimized for highthroughput processing. All samples were quantified via the Qubit® Quant-iT
dsDNA High Sensitivity Kit (Invitrogen, Life Technologies, Grand Island, NY) to
ensure that they met minimum concentration of DNA.

To enrich the sample for bacterial 16S V4 rRNA region, DNA was amplified
utilizing fusion primers designed against the surrounding conserved regions
which are tailed with sequences to incorporate Illumina (San Diego, CA) adapters
and indexing barcodes. Each sample was PCR amplified with two differently bar
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coded V4 fusion primers and PCR products were quantified by fluorometric
method (Qubit or PicoGreen from Invitrogen, Life Technologies, Grand Island,
NY). Samples that met the post-PCR quantification minimum were pooled
equimolar and advanced for sequencing. The samples were then loaded into a
MiSeq® reagent cartridge, and then onto the instrument along with the flow cell.
After the cluster formation, the amplicons were sequenced for 250 cycles with
custom primers designed for paired-end sequencing. Resulting sequences were
then searched against the Greengenes reference database of 16S rRNA gene
sequences, clustered at 97% by uclust (closed reference OTU picking). The
longest sequence from each OTU was then assigned taxonomic classification via
Mothur’s Bayesian classifier, trained against the Greengenes database clustered at
99%. For the unidentified OTUs, we carried out BLAST search to cross reference
with closest hits from NCBI 16S rRNA database with query cover (>95%),
identity (>87%) and E value (<0.01).

Statistical analyses
The data was analyzed for the entire cohort (ALL) on a pre and post basis and
also to compare group effects after subgrouping them as described under “study
design”. OTU richness was calculated by summing unique OTUs found in each
sample. Shannon diversity was calculated utilizing the richness of a sample along
with the relative abundance of the present OTUs to calculate a diversity index.
For statistical analysis and p-value calculation, for the effect of treatment (Pre to
post treatment) and inter group difference, Wilcoxon-test and Kruskal–Wallis test
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was used to determine the effect of intervention. Permutational Analysis of
Variance (PERMANOVA) was utilized for finding significant differences among
discrete categorical or continuous variables. The samples are first randomly
reassigned to the various sample categories and then the between-category
differences were compared to the true between-category differences.
PERMANOVA utilizes the sample to sample distance matrix directly, not a
derived ordination or clustering outcome. We utilized Pearson’s correlation as a
method to correlate the microbial abundance with all our metadata.
DEseq2 package [100] was used for the univariate differential abundance of
OTUs. This package uses a negative binomial noise model for the over dispersion
and Poisson process intrinsic to the data[101]. This package takes into account
both technical and biological variability between experimental conditions.
DEseq2 was run under default settings and the p-values were adjusted with the
Benjamini-Hochberg procedure, controlling for false discovery rates.

In order to calculate correlation matrices and plot, R packages such as, corrplot,
ggplot2, dplyr, reshape2, ggridges, lattice, and stargazer were used. Statistical
analyses were carried out using R-studio, SigmaPlot Software (Systat Software
Inc, San Jose, CA) and the data were presented as mean ± S.D, unless otherwise
stated. A p-value of 0.05 or less was considered significant while a p-value of
0.05 to 0.08 was considered trend or approaching significance. The adjusted p
value by using the Benjamini-Hochberg procedure is denoted as q.
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Piphillin analysis:
This is a tool for the inference of functional capacity of the metagenome from 16S
rRNA OTU counts table and representative sequence of each OTU (Piphillin
version 6.0, Second Genome Inc, South San Francisco, CA). The representative
sequence of each OTU was searched against the database composed of 16s rRNA
sequences. A genome with the closest matched 16S rRNA sequence above the
identity cut-off was considered as the inferred genome for that OTU. In the case
of more than one nearest neighbor genomes with equal identities, the count is
equally split among those genomes. Then, inferred genome content of each
genome bin is summed. The sum is then the total metagenomics content of the
sample. The content is expressed in terms of orthologues and searched against
pathways counts in KEGG genome database. The cut-off value used in the present
analysis was 95% identity.
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3 RESULTS
Macronutrient-intake in study participants: Table 1
Nutrients
Caloric Intake
Protein(g/d)
Carbohydrate(g/d)
Total Fat (g/d)
Cholesterol (g/d)
Saturated fat (g/d)
MUFA
PUFA
Fiber

all participants, average daily intake
Baseline
Week-12
2310±1150.71
1810.95±660.81
104.71±113.87
105.57±58.85
240.07±148.29
172.76±76.57
96.58±47.94
75.44±30.11
291.62±219.10
247.82±170.88
32.15±20.22
24.42±12.36
26.16±17.39
20.14±10.31
15.49±12.25
11.91±6.98
18.54±9.49
17.83±5.97

The research participants consumed their habitual diet when the baseline data was
collected. The weight loss intervention consisting of a low-calorie, easy-to-follow,
personalized diet-plan using pre-formulated meals was started after baseline data
collection and continued until data was collected at week-12. For the intervention,
participants worked one-on-one with a coach from a commercial weight-loss program
that was available locally. The proprietary, nutritionally balanced diet is based on the
principle of portion control and energy balance. Most participants self-reported that they
felt their overall fitness and feeling of wellbeing improved after joining the weight-loss
program. However, participants who were used to longer physical activity routines
frequently self-reported thatthe overall lower daily calories to be not supportive of their
activity level. We observed a large drop-out (32.8%) from the program. Individuals who
were not on the weight-loss diet for at least 12 weeks were dropped from the study.
(Figure 1). Two major self-reported reasons for wanting to discontinue with the program
were: a) expense of buying proprietary meals and/or b) difficulty to comply with the strict
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dietary regimen. There was no such case where a participant continued on the diet but
discontinued with our study.
Gut microbiota is influenced by the variation in the macronutrient intake and total
calories consumed. The nutrient-intake varied greatly from baseline to week-12 in our
study as shown in the Table 1. Average macronutrient intakes were close to the DRI from
the 2015 Dietary Guidelines, both at baseline and at week-12. Some participants were
consuming alcohol under social context at the baseline but not at week-12 because of the
alcohol restriction policy of the program. At week-12, there was an average 21.6%
reduction in overall daily calorie intake that resulted from lower average daily
carbohydrate and fat intakes. The average carbohydrate and fat intakes were reduced by
approximately 28% and 22% respectively for all participants between baseline and week12. The protein intake per day remained almost same but due to the overall calorie
reduction, the percentage of calories coming from protein increased from 18% to 23%.
Average fiber intake was similar at the baseline and week-12.

Baseline characteristics Table 2.
Fifty-eight participants were recruited, out of which 36 participants are included in the
data analysis. (Figure 1). Among them, twenty were grouped as young adults (YA) with
an average age of 33 years, and 16 were grouped as older adults (OA) with an average
age of 62 years. The average ages for males (n= 9, 45 years) and females (n= 27, 46
years) were similar. The participants were regrouped on the basis on the differences in
their body mass index (BMI) and android to gynoid fat ratio (AG). The average BMI for
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the high BMI group (hBMI) was 38.20± 5.97, whereas, for the low BMI group (lBMI)
was 27.29± 1.84. And, the average AG ratio for high AG group (hAG) was 0.63± 0.11
whereas, 0.43± 0.06 for the low AG group (lAG). The number of participants in hBMI
group was 24 and lBMI group was 12. The AG group also had the very closely similar
numbers, hAG group had 23, and lAG group had 13 participants. Two participant had
normal BMI of <25 kg/m2 at baseline, while remaining participants were overweight,
obese, or severely obese. BMI ranged from 24.42- 51.84 kg/m2 in the cohort. Therefore,
the BMI cut off was determined based on normal+overweight (<29.9 kg/m2) and obese
ranges (>30 kg/m2). Currently there are no reference value available for a healthy AG,
therefore, the arbitrary cut-off was taken as 0.5 for both men and women. One study with
much higher number of female participants than males, has reported 50th percentile of
AG for 50 years and older Caucasian women and men are 0.46 and 0.71, respectively
[102]. Visceral fat or Android fat, i.e around the abdominal region has a strong
correlation with cardiovascular and other metabolic diseases.[103] [104]. While waist
circumference and waist:hip ratio(WH) are two common indirect estimators of visceral
fat, AG ratio obtained from DXA-scans may provide an alternate measurable outcome to
precisely determine both body-type and visceral fat.
There was a large number of dissimilar characteristics between the low and high groups
based in BMI and AG ratio. (Table 2). The average age for high BMI group was lower,
while that for the AG was higher. When their respective low group was compared, the
age difference was significant between the AG groups (p= 0.025). BW, hip, waist, total
fat mass, android fat mass, and gynoid fat mass, were higher in hBMI than lBMI (all,
p<0.001). Corresponding fat-free masses were also higher in hBMI participants.
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WH(p<0.001), hemoglobin A1C (p=0.014), systolic and diastolic blood pressures (both,
p<0.001), were higher in the hAG than the lAG group. BMI is widely used and easy to
measure so it has its own place in the clinical setting. While BMI continues to be a
routinely used indicator of metabolic wellbeing in clinical settings [105], AG ratio may
be a more precise predictive indicator of glycemic and blood pressures outcomes in an
individual. As expected however, waist circumference (p=0.011) and android fat %
(p<0.001) were higher but gynoid fat % was lower (p<0.001) in hAG group when
compared to the lAG group.

Male cohort started with an average 19 kg higher body weight than females (p=0.040)
although the BMI was similar between the groups (Table 2). However, men had a higher
AG and waist:hip ratio than women (p=0.003). Total body fat was 10% higher while fat
free mass was lower by approximately 20 kg (both, p<0.001) in females than males
(Table 2). Between the age sub-groups, OA had a higher hemoglobin A1C (p=0.015) but
lower heart rate (p<0.001) as compared to that of the YA group.

Effect of intervention on anthropometric and metabolic outcomes:
Overall effect of intervention:
Weight loss was obtained effectively in the study. Most of the participants in the study
lost more than 10% of their body weight. All but one participant was able to lose at least
7% of their baseline body weight. At week-12, 33 participants lost 10% or more, two
participants lost 7% or more, while one participant gained approximately 2% of their
respective baseline BW. Sixteen participants reached at least 50% of their weight loss
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goals at week-12. Average weight lost in 12 weeks was ~10 kg (Table 4) and the
reduction was significant in all sub-groups (Table 3 and 4), (Figure 2). The greatest
reduction of BW and BMI was in males (both, ~13%) while the least was observed in the
lAG group (both, 8.6%). As we can see in the figure 3 & 4, the Male cohort started with
the higher BMI than Female however, the Male cohort ended up with lower BMI than
Female cohort. This means that the male responded better to the treatment. Also, we can
notice in the figure 4 that the weight loss response is better with the hAG group than the
lAG group (Figures 3&4). Within all sub-groups a lowering effect in additional variables
were observed as follows (all, p≤0.05): hip and waist circumferences, systolic and
diastolic blood pressures, total fat mass, lean mass and body fat %, android fat mass,
android lean mass, and android fat %, gynoid fat and lean masses, and AG (Table 3). The
ridgeline plots in the Figure 5, 6 & 7 show that there is a clear difference in the
distribution of the BMI, Body fat percentage and AG ratio Pre to Post treatment. We can
observe the clear left shift of the distribution, which signify that the diet is effective to
lower the BMI, Body fat percentage and AG ratio across all the groups (Figure 5, 6 & 7).
Reduction in fat mass correlated with reduction in A1C (all, p≤0.03) in ALL and also in
most individual sub-groups except lBMI and lAG groups (Figure 8). At week-12, lower
heart rates were observed in men and in younger adults (both, p=0.05) but not in women
and older adults (Table 3, 4).

Differences in weight-loss response within sub-groups:
Interestingly, participants with lower BMI had a greater reduction in body fat (11%,
p=0.036), android fat % (11%, p=0.047), and AG (12%, p=0.013), compared to 6%, 5%,
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and 4%, respectively in the hBMI group indicating a potential slower response to weight
loss with higher BMIs (Table 3, S1). Although, not significant, a smaller reduction in the
corresponding fat-free masses were observed in the lBMI group when compared to hBMI
group. The average BMI of the lBMI-group shifted from the overweight range
(27.29±1.84) to healthy range (24.66±1.65) in 12 weeks, while that of the hBMI group,
though improved, was still in the obese category (38.20±5.97 to 34.32±5.79). Contrasting
to the BMI group, the high AG group had a higher reduction in waist (p= 0.056) and WH
(p= 0.007) compared with the lAG group. An association between reduction in fat mass
and hemoglobin A1C (r= 0.49, p=0.003) was generally observed and was further
augmented among the hBMI (r=0.61, p= 0.002) and hAG (r=0.55, p= 0.008) individuals
(Figure 8). This correlation was not observed in the lBMI and lAG groups (p>0.3).

Males responded to the diet more compared to females. They experienced the greater
reduction compared to the females for the following measures: Body weight of male
cohort lowered by 13% compared to 9% in the female. (p = 0.031), total fat of male
decreased by 24% in male compared to 14% in female (p= 0.001) , body fat % decreased
by 13% in male and 6% in female (p= 0.001), Android fat mass decreased 32% in male
and 19% in female (p= 0.002), Gynoid fat mass decreased 23% in male and 14% in
female (p= 0.02) , AG ratio decreased 13% in male and 5% in female and heart rate
decreased 11% in male and less than 1% in female (p= 0.05).

Changes in alpha diversity measures

39

Independent filtering reduced the total number of detected OTUs from 1,617 to 1,133 and
the number of sequences from ~9.9 M to ~9.8 M. 99.97% of sequences were classiﬁed at
phylum level, 99.91% at class and order, 93.3% at family, 57.14% at genus, 19.85% at
species, and 23.23% at strain level (Figure 7). More reads were assigned at the strain
level by utilizing Second Genome’s in-house strain database. Across all samples, mean
OTU richness ranged from 516 to 543 and was higher at week-12 compared to baseline
in ALL and females (p=0.0017, 0.050, respectively). Shannon diversity means ranged
from 4.10 to 4.15 (Figure 10). The most abundant microbial phyla were Firmicutes,
Bacteroidetes, Actinobacteria, Proteobacteria, Verrucomicrobia, Euryarchaeota,
Tenericutes and Cyanobacteria. The most abundant microbial families were
Lachnospiraceae, Ruminococcaceae, Bacteroidaceae, Porphyromonadaceae,
Rikenellaceae, Erysipelotrichaceae and Coriobacteriaceae.

Changes in relative abundance and beta diversity. Table 5. Log-fold change
data genus and species levels combined.
Samples from same subject clustered together with strong inter-individual differences.
Only subtle differences due to diet or other factors were observed by weighted ordination
and hierarchical clustering. However, PERMANOVA of distance matrices showed
association of beta diversity with age, BMI, WH, heart rate, total fat mass and
percentage, android region fat mass and percentage (all p<0.05), indicating contribution
of these factors to the overall microbiome differences among the samples. At phylum
level, Firmicutes (p=0.052) and Actinobacteria (p=0.030) decreased while Tenericutes
(p=0.060) and Euryarchaeota (p=0.050) increased at week-12, in ALL (Figure 11 and
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12). At the family level, Porphyromonadaceae was signiﬁcantly increased at week-12.
Three OTUs belonging to the genus Ruminococcus and one OTU belonging to
Parabacteroides were signiﬁcantly enriched after intervention in ALL and OA subjects
(data not shown). Twenty-one unique genus showed differential response to diet and/or
age, sex, AG ratio, and BMI differences (Table 5). Of these, Phascolactobacterium and
Oscillospira increased at week-12 preferentially in YA and OA, respectively. A
consistent difference in the microbiome features were also observed independent of the
diet between the YA and OA groups. The species of Bacteriodes plebeius and
Eubacterium biforme as well as the genus Odoribacter, Prevotella, and Paraprevotella
showed higher relative abundance in YA than OA at baseline and at week-12 (all,
q≤0.04, Table 5). It is possible that these species are linked to age related features. The
species Blautia producta (q<0.001) was higher in abundance in the hAG than the lAG
group both at baseline and at week-12 (Table 5). Euryarcheota showed a trend for an
overall higher abundance in males (q=0.07) and was present in 88% of males vs 66% of
females at baseline.

Microbiome-wide anthropometric associations; Table 6
Various associations of bacterial taxa from both Firmicutes and Bacteriodetes phyla were
observed with metabolic and anthropometric outcomes. Bacteriodes eggerthi (r=0.54,
p=<0.009) correlated with age, weight loss and BMI difference in ALL. At baseline, in
ALL, a Turicibacter sp. (r=-0.55, p=0.001) and a Christensenella sp. (r=-0.61, p=0.012)
negatively correlated with body fat %. Christensenella also negatively correlated at
baseline with body fat % in OA (r=-0.76, p=0.011, Table 5). Christensenella sp. was
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associated with healthy, lower BMI individuals [106] and short chain fatty acid
production [3]. In OA-group at baseline, Parabacteroides distasonis showed negative
correlation with A1C (r=-0.55, p=0.027, Table 5). The correlation also holds at genus
level. Association of P. distasonis with improved blood lipid profiles was previously
reported (Upadhyaya et al 2016). Also, Prevotella (r=-0.63, p=0.009) and Anaerotruncus
(r=-0.50, p=0.048) genera negatively correlated with android fat % in OA at baseline.
Prevotella and Eubacterium biforme showed negative correlations in OA-group, both at
baseline and at week-12, with android fat % (Table 6). Dorea formicigenerans showed a
similar correlation and also negatively correlated with AG, for OA at week-12.
Anaerotruncus (r=-0.61, p=0.012) negatively correlated with android fat at baseline and
A1C at week-12, in older cohort; Changes in A1C and total body fat mass at week-12
correlated in ALL. Furthermore, Coprobacillus genus positively correlated with AG ratio
(r=0.54, p=0.031), WH ratio (r=0.70, p=0.002) in older cohort, both at baseline and at
week-12. Also, Lactobacillus genus (r=0.67, p=0.001) and Bifidobacterium genus
(r=0.51, p=0.022) showed association with BMI at baseline in younger cohort, but this
correlation was lost at week-12. Species of Lactobacillus and Bifidobacterium are
generally regarded as probiotics and used for health promotion, although conflicting
evidence on their effect on weight loss has been reported [107, 108], Turicibacter showed
a negative correlation with body fat % (r=-0.66, p=0.002), gynoid fat mass (r=0.51,
p=0.026) and Ruminococcus torques (r=-0.52, p=0.019) negatively correlated with body
fat %, all at baseline in YA (Table 5). At week-12, only in YA, the genus Anaerostipes
showed negative correlation with BMI (r=-0.51, p=0.062), body fat %( r=-0.59,
p=0.026), total fat mass (r=-0.58, p=0.030) and gynoid fat mass (r=-0.54, p=0.046).
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Predicted Metabolic Functions using Piphilin
Functional inference of the metagenomic shifts at week-12 from baseline were
investigated using Piphilin (publicly available version 6.0,[109]. The KEGG hits against
Piphilin-generated KO abundance data showed potential modulation of 297 functional
pathways based on gene content predictions for protein-coding genes. Among them that
showed increase in KO abundance at week-12 in ALL include: Metabolic pathways,
carbon metabolism, glycolysis/gluconeogenesis, pyruvate metabolism, and oxidative
phosphorylation (all, p<0.05). Lowering of KO abundance was observed for starch and
sucrose metabolism as well as primary and secondary bile acids (all, p<0.05) (Table 6).
Notably, participants consumed less dietary fats, carbohydrates and sugars at week-12
compared to baseline (Table 1).
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4 DISCUSSION:
The research participants were on a nutritionally balanced diet. There are other weight
loss strategies that focus on elimination or a strict restriction of one macronutrient, such
as, low fat diet, low carbohydrate diet, a very-low carbohydrate (also known as
ketogenic) diet[110]. However, more research has shown the caloric restriction by
balancing the macro and micro nutrients to be an optimal approach for the weight loss.
This point is also supported from the finding of our study. The participants in our study
were able to lose ~10% of their overall body weight and BMI in 12 weeks. There was a
21.6% reduction of calories in the study diet from the baseline to week-12 while the
overall fiber consumption did not change significantly from baseline and there was a
slightly increase of protein from 18% to 23% in the diet. The reduction of calories was
mainly from carbohydrates and fat. Reduction of calorie and correspondingly increasing
protein and fiber intake has been one of the most popular methods of weight loss and this
approach is supported by previous research[111]. However, after losing weight, some are
unable to maintain a healthier lifestyle for long term. For others, just being on restricted
energy intake is not sustainable or their metabolic rate slows down mimicking partial
starvation state [112]. Yet, some are able to maintain low calorie diet by adjusting
macronutrients and fiber in a way to feel satiated most of the time and preventing weight
regain. In this study, we did not follow up the participants to collect data on weight
maintenance and/or regain, should it have happened. Although we saw many subtle but
significant gut microbial changes from the diet at lower taxonomic levels, there was no
major changes in the microbial community at higher levels such as Phylum. This might
be the result of a coincidental uniform fiber intake before and during the study. In this
cohort, males lost the highest percentage of body weight which corroborates with
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scientific literature[113]. Males had 20kg more lean mass at baseline than Females.
Higher fat free mass is associated to higher resting metabolic rate indicating potential for
greater and continued weight loss. This may have potentially contributed to increased
weight loss response among males in this cohort.
Excess body fat mass is associated with various form of chronic morbidities like diabetes,
hypertension, arthritis, and some form of cancers. Association of fat mass with A1C was
seen in higher BMI and AG group. The same relation was not seen in the corresponding
low-groups for BMI and AG. Substantial amount of fat-mass loss may be a pre-requisite
for lowering glycated hemoglobin and restoring healthy glucose metabolism in type 2
diabetics that is worth investigating in future.

The gut microbiome is associated with food diversity and fiber intake as we learned from
the previous literatures. In this study, fiber intake did not change from baseline to week12. Overall diversity of food items between the participants did not vary as they were
consuming pre-formulated meals and snacks. However, OTU richness
improved/increased between baseline and at week-12. This observation indicates that the
increased microbial richness may be due to weight loss and not due to increased diversity
of foods. In the previous research done by Turnbaugh et al (2009), they were able to
show the difference in microbiome in obese and lean twins. Pointing at the same
direction, our research suggests that the microbial richness may be restored to some
extent by weight loss[21].
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At phylum level, Firmicutes decreased significantly, and Bacteroidetes increased slightly
although not significant. This resulted in the change in Firmicutes to Bacteroides ratio.
The ratio is one of the markers used to check gut health [114]. We still do not have
enough evidence about what an optimal ratio is but few researches as Ley et al (2006)
supports the association of metabolic syndrome and Firmicutes to Bacteroides ratio[94].
The weight loss in our study may have contributed to the decrease in Firmicutes and
consequently changing the Firmicutes to Bacteroides ratio. Thus, weight loss potentially
improves the gut microbiome composition. However, further research is needed in this
direction to find the extent of restoration of gut microbiome possible through different
weight loss strategies and whether such restoration is sustainable and uniform across
populations.

Overall, we observed 20 differential changes at genus level between baseline and postweight loss. Various genus such as, Phascolactobacterium, Oscillospira, Odoribacter
and Phylum Euryarcheota has shown differential response in our study. No previous
literature is available on these taxa showing their effects on health. In addition,
Prevotella, Paraprevotella, Bacteriodes genera are the members of healthy microbiome.
They were more abundant in the younger cohort. This might be due to the loss of healthy
microbiome due to aging processes and other inflammatory conditions in older cohort.

Another interesting observation in our study was the negative correlation of
Christensenella with body fat % and Parabacteroides distasonis with A1C change. In a
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previous research done by Ley et al [115], the association of Christensenella with healthy
and lower BMI individual was reported. Also, Upadhyaya et al (2016) showed
Parabacteroides distasonis association with improved blood lipid profile[43]. Thus, our
findings corroborate with the previously known beneficial role of these two microbiota in
an independent cohort and present potential for these species to associate with improved
overall metabolic features after weight loss.
We had a few limitations in our study. Our study is an association study; thus, we cannot
establish causal relationship from the study. Although, we didn’t have any dropouts from
the study itself, there was a high dropouts from the program, resulting in less than ideal
sample numbers. The high dropouts from the program could be partially due to restrictive
feeding paradigm of the program that did not allow normal level of social dining as well
as prices of the proprietary food items being higher than regular food. It would be
interesting to collect data to evaluate what may help minimize drop-out rates in weightloss intervention programs to improve effectiveness. In addition, a third time point to
monitor weight stabilization phase would have been ideal however, due to the high
dropout rate mentioned earlier, that approach was not feasible. Finally, the addition of
microbial metabolites analyses in the study would have made the outcome clearer and
this could also help us establish some causal relationship.
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5

CONCLUSION:

In conclusion, the proprietary nutritionally balanced weight loss diet contributed to a
significant shift in the gut microbiome. A variety of microbiome change was observed in
different groups based on BMI, Age, Sex, and AG ratio. Based on the presented results,
new hypotheses may be developed for mechanistic investigations in future. Findings from
this thesis may inform future clinical studies investigating customization potential for the
effective weight-loss strategies.
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6 Figures:

Figure 1: Flowchart showing the number of participants and dropouts in the study.
n= number of participants.

Figure 2: Donut chart showing the percentage weight loss at week-12.
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% weight lost is shown by Red color whereas, the remaining weight at week-12 is shown
in blue. p value = <0.001

Figure 3: Line graph showing the changes in BMI from baseline to post-intervention in
Males and Females.
Mean values are shown, Males (n) = 9, Females (n) = 27, p= <0.001
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Figure 4: The line graph showing the changes in BMI from Pre to post treatment in hAG
group and lAG group.
Mean values are shown, High AG (n) = 23, Low AG (n) = 13, p value <0.001

Figure 5: Ridgeline plot showing the shift of the BMI to left in all groups.
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The left shift signifies the decrease in BMI. This was observed across all groups. All
these shifts were statistically significant (p<0.001). n = Male (9), Female (27), Older
Adults (16), Young Adults (20), Low BMI (12), High BMI (24), Low AG (13), High AG
(23)

Figure 6: Ridgeline plot showing the shift of the Body Fat Percentage to left in all groups.
The left shift signifies the decrease in BMI. This was observed across all groups. All
these shifts were statistically significant (p<0.001). n = Male (9), Female (27), Older
Adults (16), Young Adults (20), Low BMI (12), High BMI (24), Low AG (13), High AG
(23).
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Figure 7: Ridgeline plot showing the shift of the AG ratio to left in all groups.
The left shift signifies the decrease in BMI. This was observed across all groups. All
these shifts were statistically significant (p<0.05). n = Male (9), Female (27), Older
Adults (16), Young Adults (20), Low BMI (12), High BMI (24), Low AG (13), High AG
(23).

Figure 8: The correlation of the fat mass change (kg) to change in A1C.
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Figure 9: Classification of sequences. Bar plot summarizing taxonomic classification
success of sequences for all samples.
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Figure 10: Alpha diversity estimates.
Left panel: OTU richness represents the number of OTUs present in each sample. p value
= 0.017. Right panel: Shannon Diversity Index takes into account the richness and
evenness of OTUs within a sample. p value = 0.318
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Figure 11: Proportional abundance Pre-treatment.
Pie chart shows the most abundant taxa at Phylum level at baseline.

Figure 12: Proportional abundance Pre-treatment.
Pie chart shows the most abundant taxa at Phylum level at week-12
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7 TABLES:
Table 1: Comparison of dietary intake of the participants at baseline and at week-12
All
Nutrients
Baseline

Week-12

Caloric Intake

2310.0±1150.7 1811.0±660.8

Protein(g/d)

104.7±113.9

105.6±58.9

Carbohydrate(g/d) 240.1±148.3

172.8±76.6

Total Fat (g/d)

75.4±30.1

96.6±47.9

Cholesterol (g/d) 291.6±219.1

247.8±170.9

Saturated fat (g/d) 32.2±20.2

24.4±12.4

MUFA

26.2±17.4

20.1±10.3

PUFA

15.512.3

11.9±7.0

Fiber

18.5±9.5

17.8±6.0
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Table 2: Baseline Characteristics between groups
Younger
adults
(YA)
n
36
20
45.69±
33.00±
Age (Yrs)
15.75
6.94
101.62± 106.12±
Weight (Kg) 24.45
24.80
34.56±
35.05±
BMI$
7.18
7.06
120.29± 123.17±
Hip (cm)
14.41
12.99
112.66± 113.01±
Waist (cm) 18.22
18.13
Waist:Hip
0.93± 0.09 0.91± 0.10
Total Fat
41.21±
43.43±
Mass (kg)
14.35
14.71
Total Fat
Free Mass
61.05±
63.37±
(kg)
13.17
12.91
39.66±
40.02±
Total Fat % 6.86
7.07
Android Fat
Mass (kg)
3.70± 1.51 3.78± 1.64
Android Fat
Free Mass
(kg)
5.08± 1.30 5.07± 1.22
Android
Fat%
8.93± 1.34 8.60± 1.32
Gynoid Fat
Mass (kg)
6.72± 2.30 7.28± 2.31
Table 2

All

Older adults
p
(OA)

Male

16

9
<0.00 44.88±
61.56± 5.91 1
17.73
96.00±
115.93±
23.56
0.22 32.45
35.14±
33.94± 7.52 0.65 8.56
116.68±
117.22±
15.69
0.18 12.99
112.23±
119.54±
18.92
0.90 22.6
0.96± 0.07 0.18 1.01± 0.08
38.43±
39.37±
13.85
0.31 18.66
58.16±
13.33

27
45.96±
15.4
96.85±
19.66
34.36±
6.84
121.31±
14.95
110.37±
16.37
0.91± 0.08
41.82±
12.99

p

0.86
0.04
0.78
0.47
0.20
0.003
0.66

High-BMI Low-BMI p

High-AG

Low-AG

24
12
42.79±
51.5±
14.99
16.26
0.12
112.23±
<0.00
22.94
80.4± 8.09 1
38.19±
27.29±
<0.00
5.97
1.84
1
126.86± 107.14± <0.00
12.94
5.36
1
119.9±
<0.00
18.04
98.19± 5.8 1
0.94± 0.11 0.91± 0.03 0.38
47.34±
28.93±
<0.00
13.56
4.98
1

23
50.04±
16.12
106.87±
27.27
35.95±
7.59
119.96±
15.58
118.3±
19.15
0.98± 0.07
42.93±
16.25

13

65.34±
<0.001 13.53
41.71±
<0.001 6.74

52.49±
7.05

64.41±
0.004 14.81
39.27±
35.55± 5.2 0.009 7.67
<0.00
4.27± 1.51 2.56± 0.59 1
4.11± 1.64

38± 12.12
92.35±
15.3
32.09±
5.88
120.86±
12.67
102.69±
11.28
0.85± 0.06
38.15±
10.06
55.12±
6.67
40.34±
5.35

p

0.03
0.09
0.12
0.86
0.01
<0.001
0.34

39.21± 6.78 0.73

55.71±
7.11
42.04±
32.5± 6.34 5.23

3.60± 1.36

0.74

4.10± 2.13 3.56± 1.26 0.36

5.10± 1.42

0.95

9.34± 1.29

0.10

6.01± 2.15

0.10

6.48± 1.51 4.62± 0.81 <0.001 5.49± 1.33 4.26± 0.74 0.005 5.55± 1.36 4.26± 0.59 0.003
10.24±
1.17
8.49± 1.09 <0.001 8.99± 1.44 8.8± 1.16 0.71 9.58± 1.08 7.77± 0.91 <0.001
<0.00
5.90± 2.37 6.99± 2.26 0.22
7.66± 2.21 4.84± 0.9 1
6.57± 2.51 6.98± 1.95 0.62

0.24

77.10±
14.46

Female

0.04
0.660

2.96± 0.86 0.024
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Gynoid Fat
Free Mass
(kg)
Gynoid Fat
%of total
Android:Gyn
oid Ratio
A1C
Systolic BP
(mmHg)
Diastolic BP
(mmHg)
Heart rate
(bpm)

10.46±
9.94± 2.30 2.45
16.42±
16.96±
2.06
2.15
0.55± 0.13
5.56± 0.45
139.02±
16.37
83.40±
9.29
77.25±
14.07

0.52± 0.13
5.41± 0.37
134.90±
16.84
82.85±
10.51
84.60±
12.19

15.75± 1.77 0.08

12.26±
2.70
15.51±
1.95

0.60± 0.13
5.76± 0.46
144.53±
14.46

0.67± 0.14 0.51± 0.1 0.001
5.54± 0.33 5.57± 0.48 0.85
144.88±
18.57
137± 15.41 0.22

9.29± 1.99

0.13

0.07
0.02
0.08

10.76±
9.16± 1.55 <0.001 2.33
16.72±
16.24±
2.04
0.13
2.24

84.13± 7.66 0.69 86.55± 13 82.3± 7.65 0.24
<0.00 78.44±
76.84±
67.46± 9.97 1
16.23
13.57
0.77
2

10.41±
8.30± 1.09 0.001 2.56
16.78±
15.38±
1.67
0.46 1.65

0.57± 0.15 0.53± 0.09 0.41
5.56± 0.44 5.58± 0.47 0.90
140.34± 136.5±
17.08
15.3
0.52
81.08±
84.6± 9.89 7.89
0.29
79.39±
73.16±
12.5
16.48
0.22

*One Sample excluded; $BMI range- 24.42 to 51.84 kg/m ; Age range- 20 to 72.

0.63± 0.1
5.7± 0.43
145.81±
15.24
86.68±
9.22
75.4±
14.19

9.10± 1.50 0.10
18.27±
1.26
<0.001
0.42± 0.06
5.33± 0.38
127.53±
11.19
77.84±
6.53
80.38±
13.84

<0.001
0.01
<0.001
<0.001
0.32
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Table 3: Percentage difference between groups

Table

n
Age

Female %
Young adults Older adults
High-BMI
Male % mean
p (Male
mean ± SD
% mean ± SD % mean ± p (YA % mean ±
± SD (p Pre
vs
(p Pre vs
(p Pre vs
SD (p Pre vs vs OA) SD (p Pre
vs Post)
Female
Post)
Post)
Post)
vs Post)

9
0± 0 (NA)
12.86± 4.85
Weight
(<0.001)
12.86± 4.85
BMI
(<0.001)
6.25± 3.33
Hip
(<0.001)
10.59± 3.77
Waist
(<0.001)
4.6± 2.89
Waist:Hip
(0.001)
24.12± 9.3
Total Fat Mass
(<0.001)
7.19± 4.74
Total Fat Free Mass (0.002)
13.34± 7.31
Total Fat %
(<0.001)

Android Fat Mass

27
0± 0 (NA) NA
9.03± 4.29
(<0.001)
0.031
9.03± 4.29
(<0.001)
0.031
5.94± 4.17
(<0.001)
0.844
6.95± 5.31
(<0.001)
0.067
0.98± 5.59
(0.200)
0.073
13.85± 7.12
(<0.001)
0.001
5.14± 3.80
(<0.001)
0.197
5.72± 4.87
(<0.001)
0.001

32.47± 16.83 18.54± 8.28
(<0.001)
(<0.001)
0.002

20
0± 0 (NA)
9.76± 5.49
(<0.001)
9.76± 5.49
(<0.001)
6.19± 4.39
(<0.001)
7.21± 5.79
(<0.001)
1.01± 5.78
(0.250)
16.16± 9.28
(<0.001)
5.34± 4.42
(<0.001)
7.6± 5.87
(<0.001)

16
0± 0 (NA)
10.28± 3.57
(<0.001)
10.28± 3.57
(<0.001)
5.80± 3.41
(<0.001)
8.66± 4.32
(<0.001)
2.98± 4.47
(0.016)
16.74± 8.5
(<0.001)
6.05± 3.72
(<0.001)
7.66± 7.22
(<0.001)

NA
0.744
0.744
0.775
0.412
0.270
0.849
0.615
0.976

20.85± 12.82 23.48± 12.04
(<0.001)
(<0.001)
0.533

Low-BMI
% mean ±
SD (p Pre
vs Post)

p
Low-AG %
(High
mean ± SD
vs
(p Pre vs
Low
Post)
AG)
23
13
0± 0 (NA) 0± 0 (NA) NA
10.79± 4.36 8.58± 5.06
(<0.001)
(<0.001)
0.178
10.79± 4.36 8.58± 5.06
(<0.001)
(<0.001)
0.178
5.66± 4.13 6.66± 3.63
(<0.001)
(<0.001)
0.473
9.09± 4.67 5.68± 5.47
(<0.001)
(0.001)
0.056
3.6± 3.78
-1.14± 6.24
<0.001)
(0.550)
0.007
17.35± 8.61 14.77± 9.28
(<0.001)
(<0.001)
0.408
6.38± 4.09 4.38± 3.90
(<0.001)
(0.002)
0.161
7.86± 6.54 7.21± 6.41
(<0.001)
(<0.001)
0.777
22.44±
21.27±
12.72
12.21
(<0.001)
(<0.001)
0.788

High-AG %
p (High
mean ± SD
vs Low
(p Pre vs
BMI)
Post)

24
12
0± 0 (NA) 0± 0 (NA) NA
10.19± 5.44 9.58± 2.74
(<0.001)
(<0.001)
0.720
10.19± 5.44 9.58± 2.74
(<0.001)
(<0.001)
0.720
6.49± 4.43 5.07± 2.59
(<0.001)
(<0.001)
0.312
8.08± 5.95 7.42± 3.27
(<0.001)
(<0.001)
0.725
1.59± 6.17 2.46± 2.79
(0.094)
(0.010)
0.648
15.1± 8.55 19.05± 9.11
(<0.001)
(<0.001)
0.210
6.18± 4.73 4.61± 2.12
(<0.001)
(<0.001)
0.282
6.06± 4.94 10.75± 7.97
(<0.001)
(<0.001)
0.036
27.25±
19.4± 11.31 13.22
(<0.001)
(<0.001)
0.072
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12.18± 12.39
(0.020)
23.22± 10.71
Gynoid Fat Mass
(<0.001)
Gynoid Fat Free
10.03± 7.35
Mass
(0.003)
-1.08± 5.16
Gynoid Fat %
(0.560)
Android Fat:Gynoid 13.06± 11.92
Fat
(0.007)
6.14± 8.61
A1C
(0.080)
8.89± 9.05
Systolic BP
(0.017)

6.04± 8.57
(0.010)
16.36± 9.9
(<0.001)
8.08± 7.02
(<0.001)
0.23± 4.70
(0.730)
5.70± 8.98
(0.01)
3.81± 5.73
(0.010)
7.19± 10.7
(0.008)

Diastolic BP

10.88± 10.67 8.39± 10.47
10.61± 9.24 8.29± 12.9
(<0.001)
(0.009)
0.498 (<0.001)
(0.05)
0.544

10.15± 9.98 9.25± 11.74
(<0.001)
(0.017)
0.810

6.92± 16.15
(0.040)

1.28± 13.25 4.78± 18.29
(0.500)
(0.237)
0.517

Android Fat %

Heart rate

5.49± 4.80
(<0.001)
0.024
14.17± 7.11
(<0.001)
0.007
6.81± 5.46
(<0.001)
0.171
0.25± 5.20
(0.740)
0.510
4.96± 7.45
(0.005)
0.021
4.68± 8.43
(0.007)
0.672
8.2± 11.18
(0.001)
0.868
10.47±
7.92± 10.52 10.63
(0.05)
(<0.001)
0.539
-0.33±
11.01± 14.05 14.64
(0.060)
(0.740)
0.051

8.56± 6.71
(<0.001)
16.53± 7.85
(<0.001)
7.04± 4.69
(<0.001)
-0.48± 5.79
(0.760)
8.60± 9.71
(0.004)
6.44± 10.74
(0.020)
9.95± 10.5
(0.003)

5.34± 7.08 10.79± 8.20
0.340 (0.003)
(0.002)
0.047
15.89± 9.06 17.51± 8.93
0.955 (<0.001)
(<0.001)
0.615
7.96± 6.62 6.94± 4.87
0.614 (<0.001)
(<0.001)
0.640
0.92± 4.55 -2.1± 5.85
0.680 (0.290)
(0.270)
0.096
4.32± 7.90 12.32± 9.89
0.360 (0.018)
(0.002)
0.013
4.56± 8.08 5.88± 9.2
0.363 (0.013)
(0.040)
0.666
7.94± 9.82 9.2± 12.26
0.453 (<0.001)
(0.030)
0.745

-3.19± 11.85
3.85± 14.85 0.14± 16.07
(0.380)
0.049 (0.140)
(0.720)
0.500

6.67± 8.33
(0.002)
17.20± 9.14
(<0.001)
8.54± 6.10
(<0.001)
-0.25± 5.73
(0.930)
6.58± 10.23
(0.004)
5.38± 9.33
(0.010)
9.97± 10.55
(<0.001)

8.02± 7.00
(0.002)
15.08± 8.72
(<0.001)
5.97± 5.80
(0.003)
0.22± 4.1
(0.880)
7.69± 7.69
(0.004)
4.39± 6.72
(0.037)
5.67± 10.39
(0.07)

0.630
0.502
0.226
0.790
0.737
0.741
0.249
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Table 4: Post treatment characteristics:

44.88±
61.56± 5.91 <0.001 17.73
45.96± 15.4
101.24±
91.42± 22.15 95.68± 22.29 86.1± 21.47 0.202 29.63
88.15± 18.59
31.10± 6.64
31.60± 6.45
30.46± 7.04 0.616 30.57± 7.43 31.27± 6.5
110.01±
109.72±
114.12±
113.02± 14.45 115.44± 12.42 16.56
0.269 10.91
15.47
102.36±
106.88±
102.49±
103.59± 16.36 104.57± 16.27 16.92
0.694 20.85
14.88
0.91± 0.08
0.90± 0.08
0.93± 0.06 0.364 0.96± 0.10 0.89± 0.06
32.46±
30.45±
34.80± 13.12 36.69± 13.05 13.26
0.345 15.82
36.26± 12.09
54.49±
71.65±
57.53± 12.42 59.98± 12.69 11.75
0.192 14.61
52.84± 7.08
36.88± 7.80
37.19± 7.83
36.49± 8.01 0.794 28.31± 6.72 39.74± 5.85

High-BMI
(n=24)
42.79±
0.862 14.99
100.77±
0.126 21.03
0.788 34.32± 5.78
118.70±
0.436 14.29
109.88±
0.493 15.98
0.026 0.92± 0.09
40.38±
0.256 12.21
61.27±
<0.001 12.99
<0.001 39.33± 7.25

2.93± 13.74

3.02± 1.40

2.83± 1.37

0.686 2.93± 1.91 2.94± 1.19

0.981 3.46± 1.35 1.89± 0.63 0.001 3.26± 1.53

2.36± 0.82

0.056

4.63± 1.24
8.27± 1.33

4.64± 1.23
8.07± 1.43

4.63± 1.29
8.52± 1.21

0.972 5.74± 1.69 4.27± 0.80
0.329 9.01± 1.64 8.03± 1.15

0.001 4.99± 1.29 3.93± 0.80 0.014 5.04± 1.33
0.055 8.48± 1.35 7.85± 1.24 0.187 8.91± 1.05

3.92± 0.61
7.14± 1.01

0.008
<0.001

5.67± 2.16

6.17± 2.24

5.05± 1.94

0.123 4.62± 2.22 6.02± 2.06

0.093 6.51± 2.14 4.00± 0.84 <0.001 5.48± 2.23

6.02± 2.07

0.477

9.16± 2.12

9.58± 2.24

8.64± 1.93

0.192 11.06± 2.70 8.53± 1.49

0.001 9.88± 2.16 7.72± 1.12 0.003 9.52± 2.42

8.53± 1.31

0.182

16.42± 2.13

16.9± 2.18

15.82± 1.97 0.132 15.67± 2.06 16.67± 2.13 0.231 16.08± 2.31 17.10± 1.61 0.179 15.39± 1.66

18.24± 1.61

<0.001

0.51± 0.13
5.27± 0.43

0.49± 0.13
5.20± 0.37

0.39± 0.06
5.09± 0.47
120.07±
15.17

<0.001
0.052

Table S1

All (n=36)

Age (Yrs)

45.69± 15.75

Weight (Kg)
BMI
Hip (cm)
Waist (cm)
Waist:Hip
Total Fat Mass
(kg)
Total Fat Free
Mass (kg)
Total Fat %
Android Fat Mass
(kg)
Android Fat Free
Mass (kg)
Android Fat%
Gynoid Fat Mass
(kg)
Gynoid Fat Free
Mass (kg)
Gynoid Fat %of
total
Android
Fat:Gynoid Fat
A1C
Systolic BP
(mmHg)

Younger adults Older adults
p
(YA) (n=20) (OA) (n=16)

Male (n=9)

Female
(n=27)

33.00± 6.94

0.55± 0.12
5.36± 0.49
132.06±
127.88± 18.18 124.55± 17.07 19.19

0.172 0.59± 0.16
0.260 5.21± 0.30
131.22±
0.223 14.89

0.49± 0.11
5.29± 0.47
126.77±
19.27

p

Low-BMI
p
(n=12)

High-AG
ratio (n=23)

Low-AG ratio
p
(n=13)

51.5± 16.26 0.119 50.04± 16.12 38± 12.12

0.025

72.71± 7.94 <0.001 95.37± 24.82
24.66± 1.65 <0.001 32.09± 7.05
101.68±
5.17
<0.001 113.21± 16.2
107.51±
91.00± 7.66 <0.001 18.11
0.89± 0.03 0.239 0.94± 0.06

0.055
0.001

84.43± 14.77 0.158
29.35± 5.68 0.240
112.69±
11.29
0.918
96.65± 9.91
0.86± 0.06

23.68± 5.83 <0.001 35.86± 14.53 32.95± 10.47 0.531
50.07± 6.83 0.009 60.34± 14.33 52.59± 5.60
31.99± 6.68 0.006 36.45± 8.48 37.65± 6.70

0.048 0.54± 0.14 0.46± 0.09 0.090
0.640 5.30± 0.43 5.23± 0.45 0.674
130.33±
0.533 19.42
123± 14.96 0.260

0.58± 0.1
5.38± 0.38
132.30±
18.54

0.072
0.665

0.051
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Diastolic BP
(mmHg)

75.38± 9.67

73.35± 9.17

Heart rate (bpm)

74.00± 12.38

77.55± 11.18

77.93± 9.97 0.161 78.77± 7.22 74.25± 10.23 0.230 76.12± 9.87 73.91± 9.51 0.527 78.17± 8.71 70.46± 9.63
69.56±
68.55±
75.20±
71.58±
12.71
0.053 11.93
75.81± 12.2 0.130 11.85
13.58
0.416 73.69± 14.35 74.53± 8.32

0.019
0.848
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Table 5: Microbial Log fold change data:
Comparison
Post/pre:
diet effect
All

Young
Adults

Older Adults

Phylum

Genus

Species

n

Lfc, lfcse

p adj

Parabacteroides

distasonis

32/3
2

1.185,
0.25

<0.00
1

Prevotella

97otu8549

9/15

3.76, 0.93

0.010

Firmicutes

Enterococcus

unclassified

1.63, 0.49

0.035

Firmicutes

Enterococcus

1.66, 0.49

0.027

Firmicutes

Ruminococcus

97otu83887

-2.98,

0.014

Firmicutes

Phascolarctobacte
rium

97otu13651

10/7

3.85,

<0.00
1

Bacteroidete
s

Parabacteroides

distasonis

16/6

Firmicutes

Ruminococcus

97otu27180

15/5

Firmicutes

Oscillospira

97otu71987

15/1
4

Firmicutes

Ruminococcus

gauvreauii

10/8

8/12

Bacteroidete
s
Bacteroidete
s

Males

None

Females

Bacteroidete
s

Prevotella

97otu8549

Firmicutes

Ruminococcus

97otu20408

Firmicutes

Anaerostipes

97otu18915

Bacteroidete
s

Prevotella

copri

Firmicutes

Ruminococcus

97otu96826

Firmicutes

Acidaminococcus

unclassified
(103)

Bacteroidete
s

Bacteroides

eggerthii

Firmicutes

Acidaminococcus

Firmicutes

Roseburia

Bacteroidete
s

Prevotella

97otu11249

Firmicutes

Coprococcus

97otu39504

Firmicutes

Ruminococcus

97otu31137

Firmicutes

Eubacterium

biforme

Bacteroidete
s

Bacteroides

97otu84598

High AG
ratio

Low AG
ratio

32/3
0
32/3
1
17/1
6

26/2
6
19/1
8
27/2
5
23/2
2
14/1
0
21/1
5
16/1
5
27/2
7
18/1
8
18/1
8
15/1
6
15/1
7
13/1
3

1.457,
0.330
1.918,
0.501
1.326,
0.370
2.004,
0.563

0.001
0.011
0.020
0.020

4.12, 1.08

0.013

1.47, 0.46

0.058

-2.37,
0.73

0.054

3.87, 0.71
4.37, 0.69
4.54, 0.96

<0.00
1
<0.00
1
<0.00
1

-3.12,
0.90

0.030

4.76, 0.98

<0.00
1

-1.60,
0.49
-4.48,
0.83

0.031
<0.00
1

3.64, 0.82

0.001

4.51, 0.83

<0.00
1

3.33, 0.82

0.003

4.67, 0.84

<0.00
1
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Prevotella

copri

Firmicutes

Ruminococcus

97otu27180

Bacteroides

97otu4177

Sutterella

97otu3927

Bacteroides

eggerthii

Firmicutes

Enterococcus

unclassified

Firmicutes

Ruminococcus

97otu4035

Firmicutes

Coprococcus

eutactus

Firmicutes
Firmicutes

Ruminococcus
Turicibacter

97otu59409
unclassified

9/27
6/14

Firmicutes

Ruminococcus

97otu31137

5/14

Bacteroidete
s

Bacteroides

plebeius

6/14

Firmicutes

Eubacterium

biforme

6/18

Firmicutes

Turicibacter

97otu6443

9/25

Firmicutes

Ruminococcus

97otu40715

9/27

Firmicutes

Turicibacter

Bacteroidete
s

Bacteroides

97otu84807

Firmicutes

Anaerostipes

97otu18915

Bacteroidete
s

Parabacteroides

distasonis

Firmicutes

Ruminococcus

97otu31137

Bacteroidete
s

Bacteroides

plebeius

Firmicutes

Eubacterium

biforme

Bacteroides

eggerthii

Odoribacter
Paraprevotella

Bacteroidete
s
Proteobacter
ia
Bacteroidete
s
High BMI

Low BMI
Baseline
differences
Male/female

OA/YA

High/Low
AG ratio

13/1
2
12/1
2
13/1
2

Bacteroidete
s

4.36, 1.05

0.008

3.77, 0.94

0.008

3.43, 0.84

0.008

10/7

4.82, 1.20

0.008

10/7

4.36, 1.12

0.011

2.14, 0.57

0.013

-1.95,
0.58

0.033

2.39, 0.64

0.013

4.19, 1.12
2.70, 0.79
-4.38,
1.25
-4.69,
1.38
-3.88,
1.17
3.10, 0.89
-2.12,
0.63
3.09,
0.889

0.010
0.019

6/7

4.62, 1.45

0.035

10/1
4
16/2
0
12/1
3
10/1
3
12/1
8
10/1
2

-3.51,
0.99
-1.91,
0.60
-4.30,
1.05
-4.84,
1.18
-5.90,
1.06
-4.78,
1.25

unclassified
(115)

8/5

5.03, 1.33

97otu964

7/10

23/2
1
24/2
4
24/2
0

none

Bacteroidete
s
Bacteroidete
s
Bacteroidete
s
Bacteroidete
s
Bacteroidete
s

9/24

Prevotella
Bacteroides

7/12
97otu84807

8/5

-4.58,
1.37
-4.03,
1.17
-4.59,
1.34

0.017
0.019
0.021
0.018
0.019
0.026

0.017
0.035
0.005
0.005
<0.00
1
0.009
0.009
0.025
0.019
0.020
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Bacteroidete
s

Prevotella

97otu11249

18/5

5.24, 1.17

0.001

Firmicutes

Ruminococcus

97otu96826

20/1
1

4.00, 0.95

0.001

Firmicutes

Ruminococcus

97otu31137

16/9

-4.77,
0.94

<0.00
1

Sutterella

97otu3927

12/7

4.53, 1.31

0.020

Blautia

97otu16260

19/9

3.01, 0.85

Bacteroides

plebeius

14/9

6.48, 1.26

Firmicutes

Eubacterium

biforme

18/1
1

-5.92,
0.92

Bacteroidete
s

Bacteroides

eggerthii

16/6

6.09, 1.19

0.016
<0.00
1
<0.00
1
<0.00
1

Bacteroides

97otu84807

9/4

-4.98,
1.40

0.023

Bacteroides

97otu84598

3.45, 1.02

0.032

Prevotella

copri

Ruminococcus

97otu59409

-4.55,
0.85
3.97, 0.91

Firmicutes

Ruminococcus

97otu96826

<0.00
1
0.001
<0.00
1

Firmicutes

Coprococcus

eutactus

Bacteroidete
s

Bacteroides

plebeius

14/9

Firmicutes

Eubacterium

biforme

20/1
0

-2.61,
0.77
-3.98,
0.95
-6.21,
0.96

Bacteroidete
s

Bacteroides

eggerthii

14/8

6.31, 1.35

Bacteroidete
s

Bacteroides

fragilis

-3.24,
0.93

0.022

Firmicutes

Oscillospira

97otu16206

14/1
8
16/1
8

1.52, 0.47

0.028

Bacteroidete
s

Paraprevotella

unclassified
(60)

8/14

-4.92,
1.05

<0.00
1

Firmicutes

Oscillospira

97otu71987

15/1
9

2.10, 0.67

0.040

Firmicutes

Acidaminococcus

unclassified
(103)

8/8

Proteobacter
ia

Sutterella

97otu3927

Firmicutes

Coprococcus

eutactus

Bacteroidete
s

Bacteroides

plebeius

Firmicutes

Eubacterium

biforme

Proteobacter
ia
Firmicutes
Bacteroidete
s

High/Low
BMI

Bacteroidete
s
Bacteroidete
s
Bacteroidete
s
Firmicutes

24/1
2
23/1
1
24/9
20/1
1
21/1
2

5.77, 1.10

0.032
0.002
<0.00
1
<0.00
1

Post-diet
differences
Male/female
OA/YA

10/1
8
15/2
0
10/1
0
12/1
4

-4.49,
1.31
-4.63,
1.14
2.47, 0.77
-4.60,
1.30
-3.30,
1.01

0.024
0.004
0.029
0.018
0.028
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Bacteroidete
s
Bacteroidete
s
Bacteroidete
s

High/Low
AG ratio

10/9

Paraprevotella

97otu964

9/12
10/1
0
16/1
9

Prevotella

5.91, 1.14
-4.34,
1.17
-3.65,
1.21

0.011
0.049

Firmicutes

Acidaminococcus

Firmicutes

Lachnospira

Firmicutes

Roseburia

Bacteroidete
s

Paraprevotella

Firmicutes

Blautia

producta

Firmicutes
Bacteroidete
s

Anaerostipes

97otu18915

Prevotella

copri

Firmicutes

Ruminococcus

97otu96826

Firmicutes

Ruminococcus

97otu83887

23/9

5.30, 0.99

Prevotella

97otu94784

16/9

4.82, 1.04

Eubacterium

97otu61417

4.55, 1.29

Coprococcus

eutactus

9/7
23/1
2

<0.00
1
0.004
<0.00
1
<0.00
1
<0.00
1
<0.00
1
0.013

3.16, 0.79

0.003

Bacteroides

plebeius

17/4

7.07, 1.29

<0.00
1

Paraprevotella

97otu964

15/7

3.88, 1.20

0.030

Bacteroides

fragilis

3.83, 0.99

0.008

Dorea

97otu11975
unclassified
(94)

3.64, 1.06

0.026

22/7

2.94, 0.73

0.005

Bacteroidete
s
Bacteroidete
s
Bacteroidete
s
Firmicutes
Proteobacter
ia
Proteobacter
ia

Sutterella

8/8
16/2
0
16/2
0
12/1
7
23/1
3
17/9
22/1
3
21/1
0

21/1
1
18/8

2.02, 0.70

<0.00
1

Coprobacillus

Firmicutes

-4.61,
1.34
-1.77,
0.47
-1.92,
0.64
-3.76,
1.02
3.36, 0.65
3.34, 0.85
-5.37,
0.89
6.53, 0.98

0.059
0.021
0.013
0.050
0.015

Sutterella

97otu3927

17/9

4.59, 1.19

0.008

Eubacterium

biforme

17/9

-4.01,
0.95

0.005

Parabacteroides

97otu73285

13/8

4.42, 1.26

0.020

Bacteroides

eggerthii

20/9

3.30, 1.00

0.030

Odoribacter

unclassified

9/10

-5.66,
0.995

<0.00
1

Firmicutes

Dorea

97otu11975

6/19

Firmicutes

Blautia

97otu34899

7/19

Firmicutes
Bacteroidete
s
Bacteroidete
s
Bacteroidete
s
Male/Female

unclassified
(115)

Firmicutes

Bacteroidete
s
Firmicutes

High/Low
BMI

Odoribacter

-4.77,
1.19
-2.64,
0.85

0.004
0.050
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Actinobacte
ria
Bacteroidete
s

Bifidobacterium

adolescentis

9/27

Prevotella

copri

8/22

Firmicutes

Coprococcus

97otu39504

7/17

Firmicutes

Ruminococcus

97otu31137

5/12

-2.91,
0.87
-5.77,
1.12
-4.45,
1.23
-6.28,
1.31

0.026
0.001
0.010
<0.00
1
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Table 6:Healthy correlations
OA (n=16 )
A1C$
Anaerotruncus (pd, r= 0.61, p= 0.01)
P. distasonis (b, r= 0.55, p= 0.03)
Body
fat%

Christensenella (b, r= 0.76, p= 0.01)

Android
fat%

Dorea formicigenerans
(pd, r= -0.62, p= 0.01)
Prevotella (pd, r= 0.63, p=0.01; b, r= 0.53, p=0.03 )
Eubacterium biforme
(pd, r= -0.54, p=0.069;
b, r=-0.54, p=0.069)
Anaerotruncus (b, r= 0.50, p= 0.048)
None

BMI
reduction
Wt-loss
None

YA (n= 20)
none

ALL (n=36)
None

Turicibacter (b, r= 0.66, p= 0.002)
Ruminococcus
torques (b, r= -0.52,
p= 0.02)
Anaerostipes (pd, r=
-0.59, p= 0.03)
None

Turicibacter (b, r=
-0.55, p= 0.001)
Christensenella (b,
r= -0.61, p= 0.01)

None

None

*B. eggerthii (r=
0.54, p= 0.0007)
None
*B. eggerthii (r=
0.56, p= 0.0004)
pd= post-diet, b= baseline; *same correlation was also observed for High-BMI group.
$
Post-diet, Desulfovibrio sps correlated with higher A1C in females, high-BMI, high-AG
ratio groups (all, r=0.52, p≤ 0.03), as well as in older adults (r=0.60, p= 0.050). At
baseline, B.uniformis negatively correlated with age (r= -0.47, p=0.004);
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